Inclusion Criteria:~1. Provision of informed consent prior to any study specific procedures.~2. Have a
diagnosis of probable AD per McKhann et al. criteria~3. Have a body mass index (BMI) â‰¥23~4. Age 50-85~5. Have a
Mini Mental Status Exam (MMSE) score of 15-26 (inclusive) at screening visit~6. Have a reliable and competent
study partner who is willing to accompany the participant to all study visits, monitor compliance of study
medication administration, and observe/report any changes in the participant's health throughout the study
duration~7. Are on stable doses of concurrent medications for at least 4 weeks prior to the screening visit~8.
Speaks English as his/her primary language.~9. Females of child-bearing potential (i.e., pre-menopausal) must
have a negative urine pregnancy test at the screening visit and must agree to use of contraception throughout
the trial and for 30 days after the last dose of study medication. The approved methods of contraception are
abstinence, the consistent use of an approved oral contraceptive (birth control pill or the pill), an
intrauterine device (IUD), hormonal implants, contraceptive injection, double barrier method (diaphragm with
spermicidal gel or condom with contraceptive foam).~
